Experiments with liposomes containing different gangliosides, including GM3, and loaded with cancer antigens resulted in increased antigen presentation by human IFNα-treated monocyte-derived DCs, monocytes, or enriched blood CD169+ Axl+ Siglec-6+ DCs to antigen-specific T cell clones [190,196]. The gene discussed is SIGLEC1; the disease is cancer.